TY - JOUR
T1 - Agency in the fentanyl era
T2 - Exploring the utility of fentanyl test strips in an opaque drug market
AU - Weicker, Noelle P.
AU - Owczarzak, Jill
AU - Urquhart, Glenna
AU - Park, Ju Nyeong
AU - Rouhani, Saba
AU - Ling, Rui
AU - Morris, Miles
AU - Sherman, Susan G.
N1 - Funding Information:
The research team would like to thank the respondents who shared their time and experience to make this study possible. We would also like to thank Rebecca Hamilton White and Sara Whaley for their contributions to the development of this manuscript. This project was supported by the Behavioral Health System of Baltimore ( AS019-HRO-JHPH ) and the Maryland Department of Health and Mental Hygiene through Substance Abuse and Mental Health Services Administration block grant ( 128188 ). SR is supported by National Institute for Drug Abuse/National Institute of Health ( T32DA007292 ). SGS and JNP are supported by the Johns Hopkins University Center for AIDS Research ( 1P30AI094189 ). The funders had no role in the study design, data collection, or analysis and interpretation of the results, and this paper does not necessarily reflect the views or opinions of the funders.
Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/10
Y1 - 2020/10
N2 - Background: In Baltimore, the emergence of fentanyl and its analogues exacerbated an existing heroin crisis and increased uncertainty about drug composition and potency. In an effort to reduce overdoses, harm reduction organizations and health departments across the U.S. began distributing fentanyl test strips, a low barrier, inexpensive drug checking strategy. Studies show that people who use drugs (PWUD) frequently suspect that their drugs contain fentanyl and are interested in using fentanyl test strips to check their drugs; however, some people question their usefulness in regions where fentanyl presence is assumed. Understanding the utility of fentanyl test strips in fentanyl-saturated markets is a priority to best tailor interventions. Methods: In-depth interviews (N = 20) were conducted with individuals who reported recent (past 30 days) opioid use in Baltimore, MD. Results: Fentanyl was viewed as pervasive, dangerous, and difficult to avoid in the local drug supply. This dominant narrative characterized PWUD as disempowered by the heightened unpredictability of the drug market. While several strategies are used to navigate the drug market, respondents wanted more information about their drugs. In this context, fentanyl test strips were used in unique and unexpected ways to empower PWUD to be savvier market consumers, including avoiding fentanyl when there could be negative social or legal consequences, negotiating with dealers, and helping others in their social network navigate the opaque drug market. Conclusion: These findings add nuance and place fentanyl preference and use in the context of the drug market. When fentanyl presence is assumed, people used fentanyl test strips in unexpected ways to gain some control over their drug use. Novel uses for fentanyl test strips strengthen existing strategies used to navigate the drug market and mitigate overdose risk, and highlight their potential to quickly disseminate valuable information about the local drug supply.
AB - Background: In Baltimore, the emergence of fentanyl and its analogues exacerbated an existing heroin crisis and increased uncertainty about drug composition and potency. In an effort to reduce overdoses, harm reduction organizations and health departments across the U.S. began distributing fentanyl test strips, a low barrier, inexpensive drug checking strategy. Studies show that people who use drugs (PWUD) frequently suspect that their drugs contain fentanyl and are interested in using fentanyl test strips to check their drugs; however, some people question their usefulness in regions where fentanyl presence is assumed. Understanding the utility of fentanyl test strips in fentanyl-saturated markets is a priority to best tailor interventions. Methods: In-depth interviews (N = 20) were conducted with individuals who reported recent (past 30 days) opioid use in Baltimore, MD. Results: Fentanyl was viewed as pervasive, dangerous, and difficult to avoid in the local drug supply. This dominant narrative characterized PWUD as disempowered by the heightened unpredictability of the drug market. While several strategies are used to navigate the drug market, respondents wanted more information about their drugs. In this context, fentanyl test strips were used in unique and unexpected ways to empower PWUD to be savvier market consumers, including avoiding fentanyl when there could be negative social or legal consequences, negotiating with dealers, and helping others in their social network navigate the opaque drug market. Conclusion: These findings add nuance and place fentanyl preference and use in the context of the drug market. When fentanyl presence is assumed, people used fentanyl test strips in unexpected ways to gain some control over their drug use. Novel uses for fentanyl test strips strengthen existing strategies used to navigate the drug market and mitigate overdose risk, and highlight their potential to quickly disseminate valuable information about the local drug supply.
KW - Drug checking
KW - Empowerment
KW - Fentanyl
KW - Fentanyl test strip
KW - Harm reduction
UR - http://www.scopus.com/inward/record.url?scp=85089001179&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089001179&partnerID=8YFLogxK
U2 - 10.1016/j.drugpo.2020.102900
DO - 10.1016/j.drugpo.2020.102900
M3 - Article
C2 - 32769054
AN - SCOPUS:85089001179
SN - 0955-3959
VL - 84
JO - International Journal of Drug Policy
JF - International Journal of Drug Policy
M1 - 102900
ER -